AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.219
+0.006 (2.57%)
At close: Jan 21, 2025, 4:00 PM
0.233
+0.014 (6.43%)
After-hours: Jan 21, 2025, 7:57 PM EST
AIM ImmunoTech Employees
As of December 31, 2023, AIM ImmunoTech had 28 total employees, including 26 full-time and 2 part-time employees. The number of employees increased by 4 or 16.67% compared to the previous year.
Employees
28
Change (1Y)
4
Growth (1Y)
16.67%
Revenue / Employee
$6,786
Profits / Employee
-$854,607
Market Cap
13.99M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
AIM News
- 6 days ago - AIM ImmunoTech Highlights Key 2024 Achievements and Outlines Upcoming 2025-26 Value-Driving Milestones - GlobeNewsWire
- 5 weeks ago - AIM ImmunoTech Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards - GlobeNewsWire
- 5 weeks ago - AIM ImmunoTech Announces Election of Three Incumbent Board Members at Annual Meeting - Business Wire
- 5 weeks ago - AIM ImmunoTech Reminds Shareholders to Vote “FOR” All Four Incumbent Board Members on the WHITE Universal Proxy Card - Business Wire
- 5 weeks ago - Kellner Group Denounces False Rumors About AIM Short Selling and Demands Immediate Accountability from Incumbent Board - GlobeNewsWire
- 5 weeks ago - AIM ImmunoTech Urges Shareholders to Vote on the WHITE Universal Proxy Card “FOR” All Four Incumbent Board Members - Business Wire
- 5 weeks ago - AIM ImmunoTech Expands Patent Portfolio with New Netherlands Composition and Methods Patent Covering Ampligen for Use in the Post-COVID Condition of Fatigue - GlobeNewsWire
- 5 weeks ago - Kellner Group Announces Support from Another Former AIM Senior Executive - GlobeNewsWire